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Traditional methods of gene discovery, candidate gene
and linkage approaches, have yielded very few pancreatic
cancer susceptibility loci, such that genetic basis of
~90% of the familial clustering of pancreatic cancer is
unknown. The recent advances and cost reductions in
genome sequencing have enabled us to identify pancrea-
tic cancer susceptibility genes through exomic sequen-
cing patients with a family history of pancreatic cancer.
Individuals that have an inherited tumor suppressor
gene often lose the wild- type allele through loss of het-
erozygosity or somatic mutation. Therefore, we exam-
ined a patient’s tumor and germ-line DNA for genes
with evidence of both inherited and somatic variants
that were likely to result in the absence of a functional
protein in the patient’s tumor. We also analyzed data on
normal genetic variation in published databases and in
individuals without pancreatic cancer. These analyses
identified PALB2 as candidate pancreatic cancer gene.
T h er o l eo fPALB2 in familial pancreatic cancer was
validated by studying an additional 96 pancreatic cancer
patients. Large-scale follow-up studies of over 500 famil-
ial pancreatic cancer patients are currently underway.
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